Section of Colon and Rectal Surgery
Surgeons in the University of Cincinnati (UC) section of colon and rectal surgery treat benign, malignant and inflammatory conditions of the colon, rectum, and anus. Patients with colorectal cancer and polyposis syndromes, inflammatory bowel disease and other colitides, rectal prolapse and fecal incontinence, hemorrhoids and other benign anorectal disorders are seen at The Christ Hospital Medical Office Building, UC Health Physician Offices in Clifton and West Chester, and the Veterans Affairs Medical Center.
Cutting-edge surgical techniques are offered at each of the hospitals where the colon and rectal surgeons work. Minimally invasive advanced laparoscopic, robotic, and transanal surgical procedures are available to patients with both benign and malignant diseases of the colon and rectum. Our surgeons have expertise in transanal minimally invasive surgery (TAMIS) for large rectal polyps and early rectal cancers. Robotic surgery, which allows superior visualization of pelvic anatomy and fine dissection in the pelvis, is also offered. These minimally invasive approaches are associated with less discomfort and a quicker return to normal activity than with traditional surgical approaches, and are appropriate for patients with a wide range of diseases.
Colorectal cancer patients are treated in collaboration with medical oncology, radiation oncology, and the hepatobiliary surgeons from the UC Cancer Institute. These patients benefit from coordination of care across specialties, with surgery performed in a timely manner following neo-adjuvant treatment. Our multidisciplinary efforts to treat rectal cancer include a tumor board and clinical trials at UC Medical Center.
Patients undergoing elective abdominal operations for benign or malignant disease are placed on what is called an “enhanced recovery pathway.” This approach has many elements that are all designed to accelerate recovery following major abdominal surgery, providing patients with the ability to return to their normal level of functioning at a much quicker rate than what has previously been achieved. Specifically, use of non-opioid pain medications decreases the incidence of adverse effects experienced with conventional opioids, such as slowed bowel function and narcotic abuse and dependence. The results of this pathway have been dramatic, with significant decreases in length of hospital stay and increases in patient satisfaction scores.
The team is one of only a few groups of colorectal surgeons in the Tristate area offering the Interstim device for the treatment of fecal incontinence.
Academic pursuits of our colorectal surgeons include clinical trials, novel surgical techniques and innovative treatments for many colorectal disorders. UC colorectal research outcomes have been presented at national and international meetings.
Ian M. Paquette, MD (Interim Director, Section of Colon and Rectal Surgery)
Janice F. Rafferty, MD
Jonathan R. Snyder, MD
Earl "Tommy" Thompson, MD